Rehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
School of Medical Technology and Engineering, Zhengzhou Railway Vocational and Technical College, Zhengzhou, Henan, China.
J Orthop Surg Res. 2023 Oct 17;18(1):779. doi: 10.1186/s13018-023-04198-2.
Acupuncture has been used to relieve chronic pain in patients with knee osteoarthritis (KOA), but the evidence is contradictory. Therefore, we carefully designed a double-dummy randomized controlled trial (RCT) to explore the therapeutic effect of acupuncture for KOA.
METHODS/DESIGN: A total of 138 eligible participants with KOA who consent to participate will be randomly divided into Groups A, B, and C in a ratio of 1:1:1. Participants in Group A will receive verum acupuncture and placebo gel, while those in Groups B and C will be treated with diclofenac diethylammon gel and sham acupuncture, sham acupuncture and placebo gel, respectively. The patients will receive 4 weeks of treatment, five times a week, including acupuncture treatment once a day for 30 min and gel treatment three times a day. The primary outcome will be the change of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at week 4. The secondary outcomes will include visual analog scale (VAS), Arthritis Quality of Life Measurement Scale Simplified Scale (AIMS2-SF), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI) and Credibility/Expectancy Questionnaire. The evaluation will be performed at baseline, week 4, 8, and 12 after randomization.
This double-dummy RCT used diclofenac diethylammon gel as a positive control, and the completion of this trial will provide detailed and accurate evidence of the efficacy and safety of acupuncture for KOA.
China Clinical Trials Registry No.ChiCTR2100043947. Registered on September 24, 2020. https://www.chictr.org.cn/showproj.html?proj=122536 .
针灸已被用于缓解膝骨关节炎(KOA)患者的慢性疼痛,但证据相互矛盾。因此,我们精心设计了一项双盲随机对照试验(RCT)来探讨针灸治疗 KOA 的疗效。
方法/设计:共有 138 名符合条件的 KOA 患者同意参加,将他们以 1:1:1 的比例随机分为 A、B 和 C 三组。A 组患者接受真针刺和安慰剂凝胶治疗,B 组和 C 组患者分别接受双氯芬酸二乙胺凝胶和假针刺、假针刺和安慰剂凝胶治疗。患者将接受 4 周的治疗,每周 5 次,包括每天针刺治疗 30 分钟和每天凝胶治疗 3 次。主要结局将是第 4 周时的 Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC)变化。次要结局包括视觉模拟量表(VAS)、关节炎生活质量测量量表简化量表(AIMS2-SF)、贝克焦虑量表(BAI)、贝克抑郁量表(BDI)和可信度/期望问卷。评估将在随机分组后基线、第 4、8 和 12 周进行。
这项双盲 RCT 使用双氯芬酸二乙胺凝胶作为阳性对照,该试验的完成将为针灸治疗 KOA 的疗效和安全性提供详细和准确的证据。
中国临床试验注册中心编号 ChiCTR2100043947。于 2020 年 9 月 24 日注册。https://www.chictr.org.cn/showproj.html?proj=122536。